Literature DB >> 15941750

Antibiotic prescription in primary health care: clinical and economic perspectives (Catalonia, Spain).

Josefina Caminal1, Joan Rovira.   

Abstract

OBJECTIVE: To quantify clinical inappropriateness of antibiotic prescription and its costs in primary health care.
METHODS: 2470 cases of infectious disease during 1998 were analysed.
RESULTS: Of all cases, 69.9% did not require antibiotic treatment. Global clinical inappropriateness amounted to 43.7%, rising to 56.7% with the introduction of economic criteria. Treatment unnecessary but antibiotic provided (27.9%) represented the most important category. Costs of inappropriateness reached 68.4% of the estimated total cost.
CONCLUSION: Appropriate antibiotic use should be focused on reducing antibiotic prescription when not indicated and restraining the use of penicillins maintaining restrictive and adequate health policies, and also achieving co-responsibility from the general population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15941750     DOI: 10.1093/eurpub/cki080

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  3 in total

1.  [High exposure to antibiotics in the population and differences by sex and age].

Authors:  M Catalina Serna; Esther Ribes; Jordi Real; Leonardo Galván; Eduardo Gascó; Pere Godoy
Journal:  Aten Primaria       Date:  2010-12-08       Impact factor: 1.137

2.  [Variability between health areas in antibiotic consumption among pediatric outpatients of Principado de Asturias, Spain (2005-2018)].

Authors:  L Calle-Miguel; G Modroño Riaño; A I Iglesias Carbajo; M A Alonso Álvarez; C Vicente Martínez; G Solís Sánchez
Journal:  Rev Esp Quimioter       Date:  2021-01-26       Impact factor: 1.553

Review 3.  Does the problem begin at the beginning? Medical students' knowledge and beliefs regarding antibiotics and resistance: a systematic review.

Authors:  Natalia Nogueira-Uzal; Maruxa Zapata-Cachafeiro; Olalla Vázquez-Cancela; Ana López-Durán; Maria T Herdeiro; Adolfo Figueiras
Journal:  Antimicrob Resist Infect Control       Date:  2020-11-03       Impact factor: 4.887

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.